Rolling Boulder Investment
1
22M
1
- Areas of investment
Summary
Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2019.
Among the most popular portfolio startups of the fund, we may highlight Sirnaomics. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. Among the most popular fund investment industries, there are Biopharma, Biotechnology.
The typical case for the fund is to invest in rounds with 4 participants. Despite the Rolling Boulder Investment, startups are often financed by Value Measured Investment Limited, Sangel Biomedical Venture Capital, Qianhai Shenghui Investment. The meaningful sponsors for the fund in investment in the same round are Rich Yield Capital, Legend Sky Investment, CR-CP Life Sciences Fund.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Investments by industry
- Biotechnology (1)
- Biopharma (1)
- Drug Discovery (1)
- Pharmaceutical (1)
- Medical Device (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Sirnaomics | 29 Apr 2019 | Biotechnology, Drug Discovery, Medical Device, Pharmaceutical, Biopharma | Late Stage Venture | 22M | United States, Maryland |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.